Showing results (81-90 of 295) with videos related to
Sort By:
Pageof 30
JAMA Ophthalmology|March 5, 2026
Intracameral Cefuroxime Use in Cataract Surgery After Penicillin Allergy ReclassificationKarthik Reddy, Paul Workman, Greg Eschenauer, et al.Cancer Research|January 20, 2004
The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathwaySteven R Whittaker, Mike I Walton, Michelle D Garrett, et al.Frontiers in Pediatrics|June 6, 2018
Congenital Extra-Ventricular (Ganglio)Neurocytoma of the Brain Stem: A Case ReportMarta Piras, Evelina Miele, Angela Di Giannatale, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Establishment and characterization of acquired resistance to the farnesyl protein transferase inhibitor R115777 in a human colon cancer cell lineVictoria Smith, Martin G Rowlands, Elaine Barrie, et al.Nature Reviews. Clinical Oncology|March 25, 2021
Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug developmentAbhijit Pal, Rajiv Shinde, Manuel Selvi Miralles, et al.Nature Reviews. Cancer|June 11, 2010
Envisioning the future of early anticancer drug developmentTimothy A Yap, Shahneen K Sandhu, Paul Workman, et al.Progress in Cell Cycle Research|November 5, 2003
The contemporary drug development process: advances and challenges in preclinical and clinical developmentMichelle D Garrett, Mike I Walton, Edward McDonald, et al.Rapid Communications in Mass Spectrometry : RCM|August 31, 2006
Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of the novel anticancer agent 17-DMAG in human plasmaJavier Moreno-Farre, Yasmin Asad, Simon Pacey, et al.Current Topics in Medicinal Chemistry|July 18, 2006
Discovery and development of pyrazole-scaffold Hsp90 inhibitorsEdward McDonald, Keith Jones, Paul A Brough, et al.Journal of Biomolecular Screening|August 7, 2004
High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinaseChongbo Sun, Yvette Newbatt, Leon Douglas, et al.Pageof 30